{"url_path":"/sec/betrf/10-k/2026/item-9","section_key":"item-9","section_title":"Item 9 The Offer and Listing**","topic":"sec","document":{"doc_type":"20-F","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/1464165/0001477932-26-003553-index.html","accession_number":"0001477932-26-003553","cik":"0001464165","ticker":"BETRF","issuer_name":"BetterLife Pharma Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1464165/0001477932-26-003553-index.html","primary_entity_key":"0001464165","primary_entity_name":"BetterLife Pharma Inc."},"word_count":144,"has_tables":true,"body_markdown":"**Item 9. The Offer and Listing**\n\n \n\n**A. Offer and Listing Details**\n\n \n\nThe following table sets forth the high and low sales prices of our common shares listed on the CSE for the periods indicated below:\n\n \n\n**Quarter Ended**\n\n \n\n**High**\n\n \n\n \n\n**Low**\n\n \n\nJanuary 31, 2026\n\n \n$0.07\n \n\n \n$0.04\n \n\nOctober 31, 2025\n\n \n$0.10\n \n\n \n$0.05\n \n\nJuly 31, 2025\n\n \n$0.14\n \n\n \n$0.08\n \n\nApril 30, 2025\n\n \n$0.16\n \n\n \n$0.08\n \n\nJanuary 31, 2025\n\n \n$0.18\n \n\n \n$0.10\n \n\nOctober 31, 2024\n\n \n$0.20\n \n\n \n$0.09\n \n\nJuly 31, 2024\n\n \n$0.19\n \n\n \n$0.11\n \n\nApril 30, 2024\n\n \n$0.16\n \n\n \n$0.08\n \n\n \n\n**B. Plan of Distribution**\n\n \n\nNot applicable.\n\n \n\n**C. Markets**\n\n \n\nOur common shares are quoted on the Canadian Securities Exchange, listed for quotation on December 19, 2017, under the Symbol “BETR”. Our common stock is also quoted on the OTCQB, listed for quotation on April 13, 2010, under the Symbol “BETRF”.\n\n \n\n**D. Selling Shareholders**\n\n \n\nNot applicable.\n\n \n\n**E. Dilution**\n\n \n\nNot applicable.\n\n \n\n**F. Expenses of the Issue**\n\n \n\nNot applicable."}